Prosecution Insights
Last updated: April 19, 2026

Glaxosmithkline Biologicals SA

16 pending office actions

Portfolio Summary

16
Total Pending OAs
6
Final Rejections
10
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18683531 LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME RONEY, CELESTE A 1612 Non-Final OA Feb 14, 2024
18402174 BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS JACKSON-TONGUE, LAKIA J 1645 Non-Final OA Jan 02, 2024
18262073 Therapeutic Viral Vaccine CORNELIUS, CLAIRE ADRIENNE 1672 Non-Final OA Jul 19, 2023
18131557 IMMUNOGENIC COMPOSITION HINES, JANA A 1645 Final Rejection Apr 06, 2023
18001551 Shigella-Tetravalent (Shigella4V) Bioconjugate SHAHNAN SHAH, KHATOL S 1645 Non-Final OA Dec 12, 2022
18001498 MODIFIED EXOTOXIN A PROTEINS OGUNBIYI, OLUWATOSIN A 1645 Non-Final OA Dec 12, 2022
18008771 DOCK TAG SYSTEM COFFA, SERGIO 1658 Final Rejection Dec 07, 2022
18008767 GBS FERRITIN NANOPARTICLES SHAHNAN SHAH, KHATOL S 1645 Non-Final OA Dec 07, 2022
18008777 BACTERIAL IMMUNIZATION USING NANOPARTICLE VACCINE SHAHNAN SHAH, KHATOL S 1645 Non-Final OA Dec 07, 2022
17854377 PNEUMOCOCCAL CAPSULAR SACCHARIDE CONJUGATE VACCINE MORGAN, BAILEY MICHELLE 1645 Final Rejection Jun 30, 2022
17763354 IMMUNOGENIC COMPOSITIONS MORGAN, BAILEY MICHELLE 1645 Final Rejection Mar 24, 2022
17632270 PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE CHEONG, CHEOM-GIL 1645 Final Rejection Feb 02, 2022
17588425 VACCINE SHAHNAN SHAH, KHATOL S 1645 Non-Final OA Jan 31, 2022
17628667 QUANTIFICATION OF BIOCONJUGATE GLYCOSYLATION DUFFY, PATRICIA ANN 1645 Non-Final OA Jan 20, 2022
17618283 MUCOSAL VACCINE FORMULATIONS LI, BAO Q 1671 Non-Final OA Dec 10, 2021
17262098 ANTIGEN PURIFICATION METHOD WANG, RUIXUE 1672 Final Rejection Jan 21, 2021

Managing Glaxosmithkline Biologicals SA's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month